# Intensive Versus Conventional Digoxin Use in Patients With Heart Failure

> **NCT02797145** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Hospital Ana Nery** · enrollment: 200 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Digoxin dose-adjusted
- **DRUG:** Standard dose

## Key facts

- **NCT ID:** NCT02797145
- **Lead sponsor:** Hospital Ana Nery
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-05
- **Primary completion:** 2018-05
- **Final completion:** 2018-06
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2016-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02797145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02797145, "Intensive Versus Conventional Digoxin Use in Patients With Heart Failure". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02797145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*